{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/66c5fe5aca03bcdcad21a486/6a282a4a74e72c6295989abf?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Episode #51: The Shared Pillars of Cardiorenal Care","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/66c5fe5aca03bcdcad21a486/1781017094690-87c34f4d-702c-432a-a82c-e2691bb17bf7.jpeg?height=200","description":"<p>Heart failure, chronic kidney disease (CKD) and metabolic disease are deeply interconnected, yet healthcare systems have traditionally treated them as separate conditions. In this episode of Beatwise, I’m joined by Dr Andrew Frankel, Consultant Nephrologist at Imperial College Healthcare NHS Trust, to explore why cardiorenal metabolic (CRM) medicine is transforming how we care for patients.</p><p><br></p><p>We discuss the shared biology linking heart, kidney and metabolic disease, why \"creatinine fear\" continues to prevent optimal treatment, and how therapies such as SGLT2 inhibitors, finerenone and GLP-1 receptor agonists are reshaping outcomes across multiple specialties.</p><p><br></p><p>We also explore the future of integrated cardiorenal care, including multidisciplinary services, workforce education, patient-centred CRM hubs and what healthcare systems need to do next to improve outcomes while reducing fragmentation of care.</p><p><br></p><p><em>Key topics discussed:&nbsp;</em></p><ul><li>Why cardiorenal metabolic disease should be viewed as a single disease process rather than separate conditions</li><li>The common pathophysiology linking heart failure, CKD and metabolic disease</li><li>The problem with \"creatinine fear\" and premature discontinuation of life-saving therapies</li><li>The four pillars of modern cardiorenal metabolic treatment</li><li>Practical prescribing tips for SGLT2 inhibitors, including eGFR thresholds and sick day rules</li><li>Hyperkalaemia as a barrier to guideline-directed medical therapy and how to overcome it</li><li>The role of finerenone and non-steroidal MRAs in cardiorenal care</li><li>Why GLP-1 receptor agonists offer benefits far beyond weight loss</li><li>How integrated cardiorenal services can improve patient outcomes and reduce healthcare costs</li><li>The future of CRM hubs and one-stop multidisciplinary care pathways</li></ul><p><br></p><p><em>About my guest:</em></p><p>Dr Andrew Frankel is a Consultant Nephrologist at Imperial College Healthcare NHS Trust and a leading advocate for integrated kidney care, cardiorenal medicine and workforce education. He is also co-host of the educational podcast <a href=\"https://www.forkidneyssake.com/\" rel=\"noopener noreferrer\" target=\"_blank\"><em>For Kidneys' Sake</em></a>, which provides practical updates on chronic kidney disease and cardiorenal metabolic care.</p><p><br></p><p><strong>EPISODE HIGHLIGHTS:</strong></p><p>00:00 Welcome and Guest Introduction</p><p>01:29 Why Cardiorenal Medicine Matters</p><p>03:14 Creatinine Fear and GFR Misconceptions</p><p>04:31 The Four Pillars of Cardiorenal Therapy</p><p>07:53 Practical Use of SGLT2 Inhibitors</p><p>10:58 Hyperkalaemia as a Barrier to Treatment</p><p>14:22 Building Integrated Cardiorenal Services</p><p>19:04 Specialist Roles and Shared Care</p><p>20:40 GLP-1 Receptor Agonists and New Weight-Loss Therapies</p><p>23:33 Lifestyle Medicine and CRM Hubs</p><p>26:28 Closing Reflections</p><p>28:41 Final Thanks and Subscribe</p><p><br></p><p>If you enjoyed this episode, please like, rate, and subscribe to Beatwise The Podcast. Your support helps me reach more listeners and continue providing valuable content.</p><p><br></p><p>Don't forget to follow me on social media @<a href=\"https://www.instagram.com/sarah.theheartdoc/\" rel=\"noopener noreferrer\" target=\"_blank\">sarah.theheartdoc</a> for the latest updates, behind-the-scenes content, and more engaging discussions. Stay connected and be part of our growing community!</p><p><br></p><p><br></p>","author_name":"Sarah Birkhoelzer"}